MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.13648

Медицинская библиотека · Anticancer research · 2019

Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.

Oshiro Hiromichi, Tome Yasunori, Kiyuna Tasuku, Yoon Sang Nam, Lwin Thinzar M, Han Qinghong, Tan Yuying, Miyake Kentaro, Higuchi Takashi, Sugisawa Norihiko, Katsuya Yuki, Park Jun Ho, Zang Zhiying, Razmjooei Sahar, Bouvet Michael, Clary Bryan, Singh Shree Ram, Kanaya Fuminori, Nishida Kotaro, Hoffman Robert M

СтатьяПеревод в очереди

Аннотация

BACKGROUND/AIM: Liver metastasis in colorectal-cancer is a recalcitrant disease. To develop precision individualized therapy of this disease, we developed a patient-derived orthotopic xenograft (PDOX) model of colorectal-cancer liver metastasis. In the present report, we evaluated the efficacy of oral recombinant methioninase (o-rMETase) in combination with 5-fluorouracil (5-FU) and oxaliplatinum (OXA) on the colorectal-cancer liver metastasis PDOX mouse model.

MATERIALS AND

METHODS

Colorectal-cancer liver metastasis PDOX models were randomized into three groups of seven mice. Group 1, untreated control with phosphate buffered saline (PBS); Group 2, treated with 5-FU + OXA; and Group 3, treated with 5-FU + OXA + o-rMETase.

RESULTS

The colorectal-cancer liver metastasis PDOX model was resistant to 5-FU + OXA (p=0.83 at day 15 of treatment, Group 2). In contrast, the colorectal-cancer liver metastasis PDOX model was arrested by o-rMETase combined with 5-FU + OXA (p<0.01 at day 15, Group 3). No significant body-weight differences were observed among the groups.

CONCLUSION

The combination therapy of 5-FU and OXA with o-rMETase can overcome the resistance of first line drugs for colorectal-cancer liver metastasis.

Для цитирования: Oshiro Hiromichi, Tome Yasunori, Kiyuna Tasuku, Yoon Sang Nam, Lwin Thinzar M, Han Qinghong, Tan Yuying, Miyake Kentaro, Higuchi Takashi, Sugisawa Norihiko, Katsuya Yuki, Park Jun Ho, Zang Zhiying, Razmjooei Sahar, Bouvet Michael, Clary Bryan, Singh Shree Ram, Kanaya Fuminori, Nishida Kotaro, Hoffman Robert M. Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.. Anticancer research. 2019. DOI: 10.21873/anticanres.13648.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.